Infant Bacterial Therapeutics AB - Class B

NEW
OTCPK:IFTBF (Sweden)   Class B
$ 6.85 (0%) 07:08 PM EST
At Loss
P/B:
10.62
Market Cap:
$ 91.72M
Enterprise V:
$ 78.11M
Volume:
0
Avg Vol (2M):
150.00
Trade In:
Volume:
0
At Loss
Avg Vol (2M):
150.00

Infant Bacterial Therapeutics AB (IFTBF) Dividend

Infant Bacterial Therapeutics AB (IFTBF) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -6.3%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: IFTBF Dividend

Does Infant Bacterial Therapeutics AB (IFTBF) pay a dividend?

Infant Bacterial Therapeutics AB (IFTBF) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Infant Bacterial Therapeutics AB pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Infant Bacterial Therapeutics AB has returned capital to shareholders via buybacks at a rate of -6.3% over the past 3 years.

What are dividend-paying alternatives to Infant Bacterial Therapeutics AB?

For dividend-paying alternatives in Infant Bacterial Therapeutics AB's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.